序号 | 产品名称 | 产品数量 |
1 | Oleoyl-sn-3-Glycerophosphate | 1 |
2 | Ganglioside GD1a mixture (sodium salt) | 1 |
3 | Ganglioside B1 | 1 |
4 | Glu-R-S-P | 1 |
5 | MIBG sulfate | 1 |
6 | 硫酸碘苄胍 EP标准品 | 1 |
7 | Polydeoxyribonucleotide(Sodium salt) | 1 |
8 | AI3 00865 | 1 |
9 | AI300865 | 1 |
10 | AI3-00865 | 1 |
11 | IMM-03 | 1 |
12 | 4-(Dimethylamino)-1-methylpyridinium (iodide) | 1 |
13 | PD-142676 | 1 |
14 | UNII-7U374ZW3YB | 1 |
15 | Exendin-3/4 (59-86) | 1 |
16 | Exendin-3/4 (64-86) | 1 |
17 | Exendin-3/4(64-86) | 2 |
18 | Exendin-4 peptide derivative acetate | 1 |
19 | Exendin-4 peptide derivative | 2 |
20 | GLP-1(7-36), amide acetate | 1 |
21 | GLP-1(7-36) Acetate | 1 |
22 | Human GLP-1-(7-36)-amide Acetate | 1 |
23 | 2-Furoyl-LIGRLO-amide TFA(729589-58-6,FREE) | 1 |
24 | Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA | 1 |
25 | Topoisomerase I inhibitor 6 | 1 |
26 | 2393082-56-7 | 1 |
27 | TRAP-6 Peptide (trifluoroacetate salt) | 1 |
28 | Protease-Activated Receptor-1, PAR-1 Agonist | 1 |
29 | PAR 4 (1-6) | 1 |
30 | PAR2 (1-6) (mouse, rat) | 1 |
31 | Protease-Activated Receptor-3 (PAR-3) (1-6), human | 1 |
32 | RO 236152 | 2 |
33 | RO-23-6152 | 1 |
34 | PZ 128 | 1 |
35 | Protease-Activated Receptor-1, PAR-1 Agonist TFA | 1 |
36 | RWJ53308 | 1 |
37 | RWJ 53308 | 1 |
38 | RWJ-53308 | 1 |
39 | DHDMIQK(KAP) | 1 |
40 | Odatroltide | 1 |
41 | 1639303-73-3 | 1 |
42 | Lytixar | 1 |
43 | LTX-109 | 1 |
44 | LTX109 | 1 |
45 | LTX 109 | 1 |
46 | Voxvoganan | 1 |
47 | MS-438 | 1 |
48 | MS 438 | 1 |
49 | MS 437 | 1 |
50 | MS-437 | 1 |
51 | VA K 14 HCl | 1 |
52 | VAK14 HCl | 1 |
53 | VAK14 Hydrochloride | 1 |
54 | Ro 48-5033 | 1 |
55 | Antibiotic P42-1 | 1 |
56 | Antibiotic P42-C | 1 |
57 | Thrombin Receptor Agonist Peptide (trifluoroacetate salt) | 1 |
58 | Thrombin Receptor Agonist Peptide(trifluoroacetate salt) | 2 |
59 | A127722 | 1 |
60 | A-127722 | 1 |
61 | Macitentan (n-butyl analogue) | 1 |
62 | ACT-064992 D4 | 1 |
63 | BP 1.137 | 1 |
64 | BP 1137 | 1 |
65 | BP-1.137 | 1 |
66 | BP1.137 | 1 |
67 | BP1137 | 1 |
68 | BP-1137 | 1 |
69 | Dexbrompheniraminum | 1 |
70 | Brompheniramine d- | 1 |
71 | Disophrol | 1 |
72 | Drixoral | 1 |
73 | D-Brompheniramine | 1 |
74 | Deoxycholic acid(Choleic acid Droxolan Pyrochol Septochol) | 1 |
75 | UNII-48M66E9ER2 | 1 |
76 | DA11004 | 1 |
77 | 卡普瑞林 | 1 |
78 | CP 424,391 | 1 |
79 | Brr2 Inhibitor 9 | 1 |
80 | Lactosylceramides (bovine buttermilk) | 1 |
81 | S1P1 agonist 5 | 1 |
82 | SAB378 | 1 |
83 | SAB 378 | 1 |
84 | SAB-378 | 1 |
85 | GW-1000 | 1 |
86 | GW 1000 | 1 |
87 | GW1000 | 1 |
88 | SPM 242 | 1 |
89 | Sphingosine-1-phosphate (d16:1) | 1 |
90 | RP-101075 | 1 |
91 | APD334 L-Arginine | 1 |
92 | Apamin TFA (24345-16-2 free base) | 1 |
93 | Apamin TFA(24345-16-2 free base) | 1 |
94 | BML258 | 1 |
95 | BML 258 | 1 |
96 | Nrf2 Activator IV | 1 |
97 | Nrf2 Activator-IV | 1 |
98 | 屈 | 2 |
99 | (E)-2-((1,4-二甲基哌嗪-2-亚基)氨基)-5-硝基-N-苯基苯甲酰胺 | 1 |
100 | MOG (35-55), human | 1 |